LATEST NEWS

Bristol-Myers Squib and Pfizer Announce, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals

The Bristol-Myers Squibb-Pfizer Alliance today announced the initiation of a new randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in...

Read More

Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company

Bristol-Myers Squibb Company (NYSE:BMY) has announced that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all...

Read More

Massive Bio and The American Sexual Health Association Partner to Increase Patient Access to Cervical Cancer Clinical Trials

Massive Bio, a leader in Artificial Intelligence (AI) based oncology clinical trial enrollment, and The American Sexual Health Association (ASHA), a leader in advancing...

Read More

Quality Cancer Care Alliance Network (QCCA) Selects Integra Connect as Preferred Population Health Analytics Partner

Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced it has been selected by the Quality Cancer Care...

Read More

Thermo Fisher Scientific Introduces First Next-Generation Sequencing Platform That Delivers Specimen to Report in a Single Day

Thermo Fisher Scientific announced the launch of its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report...

Read More

Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor

Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S Food...

Read More

Multimedia

 Tweets

Subscribe now to receive your FREE copy of The Journal of Precision Medicine